To explore the anti-inflammatory mechanism of MS, we analysed the IL-10 expression in LPS-stimulated macrophages and found that both pre-treatment and post-treatment with MS induced the significant upregulation of IL-10 at the protein (Fig. 5A) and mRNA levels (Fig. 5B). This evidence concerns the gene IL10 and myeloid sarcoma.